Featured Research

from universities, journals, and other organizations

New Northwestern Memorial Study Demonstrates Significant Burden Staph Infections Place On Hospitals

Date:
August 9, 2005
Source:
Northwestern Memorial Hospital
Summary:
Staphylococcus aureus infections (S. aureus) create an enormous burden to hospitals by significantly increasing costs, length of patient stays and mortality rates, a Northwestern Memorial Hospital researcher found in the most comprehensive study to date, published today's Archives of Internal Medicine. The study, led by Gary Noskin, MD, an infectious diseases specialist and medical director of healthcare epidemiology and quality at Northwestern Memorial, examined two years of data from hundreds of hospitals.

Staphylococcus aureus infections (S. aureus) create an enormous burdento hospitals by significantly increasing costs, length of patient staysand mortality rates, a Northwestern Memorial Hospital researcher foundin the most comprehensive study to date, published today's Archives ofInternal Medicine. The study, led by Gary Noskin, MD, an infectiousdiseases specialist and medical director of healthcare epidemiology andquality at Northwestern Memorial, examined two years of data fromhundreds of hospitals.

"S. aureus infections represent a considerable burden to U.S.hospitals, particularly among high-risk patient populations," said Dr.Noskin. "The potential benefits to hospitals in terms of reduced use ofresources and costs, as well as improved outcomes from preventing S.aureus infections, are significant."

"There are currently a number of things being done to reducethe number of hospital-acquired S. aureus infections, including use ofantibiotics to prevent surgical site infections, consistenthand-washing and maximum barrier protections when putting in centrallines," adds Dr. Noskin. "There are also strategies to reduce S. aureusinfections that are brought into the hospital such as performing anasal swab to screen for S. aureus then attempting to eliminate it.Another important intervention is to make sure patients with certaininfections are placed in isolation."

S. aureus infection was listed as a discharge diagnosis innearly 1 percent of all hospital stays, or an average of 292,045 staysin a year, the study found. And S. aureus infection stays had, onaverage, 3 times the length of stay (14.3 vs. 4.5 days), three timesthe total charges ($48,824 vs. $14,141), and five times the risk ofin-hospital death (11.2 percent vs. 2.3 percent) than stays withoutthis infection. Even when controlling for patient differences in age,gender, race and comorbidities, the differences were significant: 9.1days in excess length of stay, $32,856 in excess charges and 4 percentin-hospital mortality.

Applying these per stay estimates to the total number of S.aureus stays in the United States in a given year results in anestimated 2.7 million days in excess length of stay, $9.5 billion inexcess charges, and close to 12,000 inpatient deaths per year. Thedifferences remained significant when also comparing hospitalizationswith S. aureus infections with other types of infections.

The study did not distinguish between infections that occurredbefore admission to the hospital or during a hospital stay. Also, theinability to measure "out of hospital" mortality, or mortalitysubsequent to the hospital stay, likely underestimates the impact of S.aureus infections on mortality.

S. aureus is a bacterium, frequently living on the skin or in the noseof a healthy person that can cause illnesses ranging from minor skininfections and abscesses, to life-threatening diseases. Long recognizedas a frequent cause of healthcare-associated infections in acute carehospitals, it is often responsible for hospital-acquired pneumonia andsurgical site infections, and is the second most common cause ofbloodstream infections. An increasing percentage of S. aureusinfections are caused by antibiotic resistant strains of the organism.

3M Healthcare was a study sponsor and financial support alsocame from a grant from the U.S. Public Health Service. According toEdwin Hedblom, health economic business manager from 3M Health Care,"no prior study has estimated the impact of S. aureus infections tothis degree, in terms of clinical and financial outcomes that includelength of stay (LOS), total charges, and in-hospital mortality, fromnationally representative data."

Patient discharge data from 994 hospitals in 28 states in 2000and 986 hospitals in 33 states in 2001 -- representing approximately 14millions inpatient stays -- was analyzed to determine the associationof S. aureus infections with length of stay, total charges andin-hospital mortality.

Other findings include:

  • Patients undergoing an orthopedic, cardiovascular, and neurosurgical procedure that have S. aureus infection spent 16.6 additional days in the hospital and at a cost of $68,944 as compared to patients without S. aureus infections.
  • Patients undergoing an orthopedic, cardiovascular or neurosurgical procedure with S. aureus infections had a nearly five-fold risk of in-hospital death compared to patients without this infection. The differential in absolute risk of mortality was greatest for cardiovascular procedures.
  • Among the hospitalizations analyzed, S. aureus infections were most likely to occur in neurosurgery stays (1.4 percent) and least likely to occur in orthopedic surgery stays (0.3 percent).


Story Source:

The above story is based on materials provided by Northwestern Memorial Hospital. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern Memorial Hospital. "New Northwestern Memorial Study Demonstrates Significant Burden Staph Infections Place On Hospitals." ScienceDaily. ScienceDaily, 9 August 2005. <www.sciencedaily.com/releases/2005/08/050809070008.htm>.
Northwestern Memorial Hospital. (2005, August 9). New Northwestern Memorial Study Demonstrates Significant Burden Staph Infections Place On Hospitals. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/08/050809070008.htm
Northwestern Memorial Hospital. "New Northwestern Memorial Study Demonstrates Significant Burden Staph Infections Place On Hospitals." ScienceDaily. www.sciencedaily.com/releases/2005/08/050809070008.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins